Profile
Dale Ritter worked as a Finance Director at PAREXEL International Corp.
He then worked as the Principal Accounting Officer & SVP-Finance at Indevus Pharmaceuticals, Inc. from 1994 to 2009.
In 2011, he worked as the Chief Accounting Officer & Senior VP-Finance at Fortress Biotech, Inc. He also worked as the Vice President-Finance at Rocket Pharmaceuticals, Inc. and Vice President-Finance & Accounting at Inotek Pharmaceuticals Corp.
Mr. Ritter holds an MBA from Babson College and an undergraduate degree from Syracuse University.
Former positions of Dale Ritter
| Companies | Position | End |
|---|---|---|
| FORTRESS BIOTECH, INC. | Director of Finance/CFO | 2012-02-22 |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Comptroller/Controller/Auditor | 2009-03-24 |
| ROCKET PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Director of Finance/CFO | - |
Xyvision Enterprise Solutions, Inc.
 Xyvision Enterprise Solutions, Inc. Information Technology ServicesTechnology Services Xyvision Enterprise Solutions, Inc. standards based content management and enterprise publishing solutions. It delivers software solutions that provide workflow, dynamic content import and support for both structured and unstructured data. The company XML content management software provides solutions for publishing, technical documentation, financial, government, aerospace and defense industries. The company is headquartered in Reading, MA. | Corporate Officer/Principal | - |
Training of Dale Ritter
| Babson College | Masters Business Admin |
| Syracuse University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Xyvision Enterprise Solutions, Inc.
Xyvision Enterprise Solutions, Inc. Information Technology ServicesTechnology Services Xyvision Enterprise Solutions, Inc. standards based content management and enterprise publishing solutions. It delivers software solutions that provide workflow, dynamic content import and support for both structured and unstructured data. The company XML content management software provides solutions for publishing, technical documentation, financial, government, aerospace and defense industries. The company is headquartered in Reading, MA. | Technology Services |
- Stock Market
- Insiders
- Dale Ritter
